Ranbaxy gets FDA approval for depression drug (IANS via Yahoo! India News)
Washington, Feb 10 (IANS) India's drug major Ranbaxy Laboratories has received the US Food and Drug Administration (FDA)'s final approval to manufacture and market its formulation for the treatment of major depressive disorders in adults.

Ranbaxy gets FDA nod to make depression drug (The Times of India)
FDA approval permitted the company to manufacture and market its formulation for the treatment of major depressive disorders in adults.